Orphan Products Development; Common European Medicines Agency/FDA Form for Orphan Medicinal Product Designation and FDA Orphan Drug Designation Request Form
ICR 201711-0910-007
OMB: 0910-0167
Federal Form Document
⚠️ Notice: This information collection may be outdated. More recent filings for OMB 0910-0167 can be found here:
Orphan Products Development;
Common European Medicines Agency/FDA Form for Orphan Medicinal
Product Designation and FDA Orphan Drug Designation Request
Form
This information is required in the
implementation and administration of the Orphan Drug Act, 21
U.S.C., Sections 526-528. The information is necessary to show that
applicants qualify and continue to qualify for the incentives and
assistance provided by the statute and regulations.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.